financetom
Forex World Market Business Cryptocurrency Commodities MAP
financetom
Business
financetom
/
Business
/
RadNet Unit Receives Expanded FDA Clearance for SmartMammo Mammography Software
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
RadNet Unit Receives Expanded FDA Clearance for SmartMammo Mammography Software
Nov 29, 2024 4:16 AM

06:45 AM EST, 11/29/2024 (MT Newswires) -- RadNet's ( RDNT ) DeepHealth unit said Friday it received expanded US Food and Drug Administration 510(k) clearance for its SmartMammo mammography software.

The unit added that its SmartMammo Dx artificial intelligence algorithm is now compatible with GE HealthCare Technologies' ( GEHC ) Senographe Pristina mammography systems.

The unit said radiologists use the SmartMammo mammography software to analyze digital breast tomosynthesis mammograms with precision.

Shares of RadNet ( RDNT ) were up 1.8% in recent Friday premarket activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-VivoPower's Tembo Extends Heads Of Agreement Exclusivity For US $838 Mln Merger With CCTS
BRIEF-VivoPower's Tembo Extends Heads Of Agreement Exclusivity For US $838 Mln Merger With CCTS
Jul 29, 2024
July 29 (Reuters) - Cactus Acquisition Corp 1 Ltd ( CCTS ) : * VIVOPOWER'S ( VVPR ) TEMBO EXTENDS HEADS OF AGREEMENT EXCLUSIVITY FOR US$838M MERGER WITH CCTS * VIVOPOWER INTERNATIONAL PLC ( VVPR ) - EXCLUSIVITY PERIOD FOR HEADS OF AGREEMENT EXTENDED TO 31 AUGUST 2024 * VIVOPOWER INTERNATIONAL PLC ( VVPR ) - EXTENSION TO ENABLE TEMBO...
 Sanofi sues Sarepta over US patents for gene therapy treatments
Sanofi sues Sarepta over US patents for gene therapy treatments
Jul 29, 2024
July 29 (Reuters) - Sanofi-owned biotech company Genzyme has sued rival Sarepta Therapeutics ( SRPT ) in Delaware federal court for allegedly infringing two patents related to Sarepta's Duchenne muscular dystrophy (DMD) treatment Elevidys. Genzyme said in the lawsuit, made public on Monday, that Sarepta mimics Genzyme's technology for modifying viruses used to deliver genes into human cells in gene-therapy...
 Element Solutions Q2 Adjusted Earnings, Net Sales Rise
Element Solutions Q2 Adjusted Earnings, Net Sales Rise
Jul 29, 2024
04:31 PM EDT, 07/29/2024 (MT Newswires) -- Element Solutions ( ESI ) reported Q2 adjusted earnings late Monday of $0.36 per share, up from $0.31 a year earlier. Analysts surveyed by Capital IQ expected $0.35. Net sales in the quarter ended June 30 rose to $612.7 million from $586.1 million a year earlier. Analysts surveyed by Capital IQ expected $608.3...
 BRIEF-Crescent Stockholders Overwhelmingly Approve Merger With SilverBow Resources
BRIEF-Crescent Stockholders Overwhelmingly Approve Merger With SilverBow Resources
Jul 29, 2024
July 29 (Reuters) - Crescent Energy Co ( CRGY ): * CRESCENT STOCKHOLDERS OVERWHELMINGLY APPROVE MERGER WITH SILVERBOW RESOURCES Source text for Eikon: Further company coverage: ...
About
Terms and Conditions Privacy policy Cookie Settings Contact Us
Services
Login register
financetom Market Personal Finance Business Economy Cryptocurrency MAP
Links
zpostcode Recruit weather mreligion Yellowpages sport constellation shopping name game directory literature Word tour furnish Lottery tftnews lyrics News digital car dir Edu Finance
Copyright 2023-2026 - www.financetom.com All Rights Reserved